LG 2716
Latest Information Update: 07 Feb 2001
At a glance
- Originator Ligand Pharmaceuticals; Wyeth
- Class Antineoplastics; Hormonal replacements; Hormones
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Menopausal syndrome
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Breast cancer in USA (Unknown route)
- 07 Feb 2001 Discontinued-Preclinical for Menopausal syndrome in USA (Unknown route)
- 18 Apr 2000 No-Development-Reported for Breast cancer in USA (Unknown route)